433 related articles for article (PubMed ID: 1678775)
1. Heterogenous graft rejection pathways in class I major histocompatibility complex-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens.
Kitagawa S; Iwata H; Sato S; Shimizu J; Hamaoka T; Fujiwara H
J Exp Med; 1991 Sep; 174(3):571-81. PubMed ID: 1678775
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of CD4+ T cells involved in anti-allo-class I H-2 immune responses. Functional discrimination between the major proliferating cells and helper cells assisting cytotoxic T cell responses.
Kitagawa S; Sato S; Azuma T; Shimizu J; Hamaoka T; Fujiwara H
J Immunol; 1991 Apr; 146(8):2513-21. PubMed ID: 1673140
[TBL] [Abstract][Full Text] [Related]
3. Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo.
Rosenberg AS; Munitz TI; Maniero TG; Singer A
J Exp Med; 1991 Jun; 173(6):1463-71. PubMed ID: 1674524
[TBL] [Abstract][Full Text] [Related]
4. Suppression of allograft responses by combining donor alloantigen-specific intravenous presensitization with suboptimal doses of FK506.
Iwata H; Kitagawa S; Sato S; Kosugi A; Hirose H; Hamaoka T; Shearer GM; Fujiwara H
Transplantation; 1993 Jul; 56(1):173-80. PubMed ID: 7687396
[TBL] [Abstract][Full Text] [Related]
5. Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.
Hori S; Kitagawa S; Iwata H; Ochiai T; Isono K; Hamaoka T; Fujiwara H
J Exp Med; 1992 Jan; 175(1):99-109. PubMed ID: 1730930
[TBL] [Abstract][Full Text] [Related]
6. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
7. Induction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells.
Kitagawa S; Sato S; Hori S; Hamaoka T; Fujiwara H
J Exp Med; 1990 Jul; 172(1):105-13. PubMed ID: 2141624
[TBL] [Abstract][Full Text] [Related]
8. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
[TBL] [Abstract][Full Text] [Related]
9. The influence of allo-class II MHC-specific Th2 cells on the generation of CD4 and CD8 cytotoxic T cells to associated class I and class II MHC alloantigen.
Wood PJ; Cossens IA
Clin Exp Immunol; 1995 May; 100(2):359-65. PubMed ID: 7743677
[TBL] [Abstract][Full Text] [Related]
10. Mediation of skin allograft rejection in scid mice by CD4+ and CD8+ T cells.
Shelton MW; Walp LA; Basler JT; Uchiyama K; Hanto DW
Transplantation; 1992 Aug; 54(2):278-86. PubMed ID: 1353912
[TBL] [Abstract][Full Text] [Related]
11. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo.
Lee RS; Grusby MJ; Glimcher LH; Winn HJ; Auchincloss H
J Exp Med; 1994 Mar; 179(3):865-72. PubMed ID: 8113680
[TBL] [Abstract][Full Text] [Related]
12. Suppression of allograft responses by combining alloantigen-specific i.v. pre-sensitization with suboptimal doses of rapamycin.
Iwata H; Nagano T; Toyo-oka K; Hirose H; Hamaoka T; Fujiwara H
Int Immunol; 1994 Jan; 6(1):93-9. PubMed ID: 7511931
[TBL] [Abstract][Full Text] [Related]
13. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
[TBL] [Abstract][Full Text] [Related]
14. Xenogeneic iso-skin graft and mixed lymphocyte reaction studies using HLA-DP transgenic mice.
Hagihara M; Shimura T; Takebe K; Munkhbat B; Sato T; Tsuchida F; Sato K; Tsuji K
Transpl Immunol; 1996 Sep; 4(3):220-6. PubMed ID: 8893453
[TBL] [Abstract][Full Text] [Related]
15. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.
Dalloul AH; Ngo K; Fung-Leung WP
Eur J Immunol; 1996 Jan; 26(1):213-8. PubMed ID: 8566069
[TBL] [Abstract][Full Text] [Related]
16. The lymphoid cell populations required for induction of tolerance of different subsets of alloantigen-reactive T cells.
Sato S; Iwata H; Kitagawa S; Kokudo S; Okuno K; Hamaoka T; Fujiwara H
Transplantation; 1991 Nov; 52(5):862-7. PubMed ID: 1835197
[TBL] [Abstract][Full Text] [Related]
17. The T cell populations mediating rejection of MHC class I disparate skin grafts in mice.
Rosenberg AS
Transpl Immunol; 1993; 1(2):93-9. PubMed ID: 7915953
[No Abstract] [Full Text] [Related]
18. Mechanism of the rejection of major histocompatibility complex class I-disparate murine skin grafts: rejection can be mediated by CD4+ cells activated by allo-class I + II antigen in CD8+ cell-depleted hosts.
Kobayashi E; Kawai K; Ikarashi Y; Fujiwara M
J Exp Med; 1992 Aug; 176(2):617-21. PubMed ID: 1354244
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
Muraoka S
Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
[TBL] [Abstract][Full Text] [Related]
20. T cell subsets required for in vivo and in vitro responses to single and multiple minor histocompatibility antigens.
Wettstein PJ; Korngold R
Transplantation; 1992 Aug; 54(2):296-307. PubMed ID: 1353915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
